Table 2. Estimates of SARS-CoV-2 Infections and COVID-19–Associated Hospitalizations and Deaths Prevented by Direct Effects of COVID-19 Vaccination in the US, December 1, 2020, to September 30, 2021.
| Age group, y | No. prevented (95% UI) | ||
|---|---|---|---|
| Infections | Hospitalizations | Deaths | |
| 18-49 | 13 700 000 (10 000 000-18 600 000) | 301 000 (260 000-367 000) | 14 000 (7500-20 000) |
| 50-64 | 8 100 000 (5 800 000-12 000 000) | 525 000 (454 000-646 000) | 66 000 (40 000-94 000) |
| ≥65 | 4 600 000 (3 500 000-6 100 000) | 759 000 (622 000-946 000) | 154 000 (105 000-214 000) |
| Total (≥18 y)a | 26 700 000 (22 000 000-34 000 000) | 1 600 000 (1 400 000-1 800 000) | 235 000 (175 000-305 000) |
Abbreviation: UI, uncertainty interval.
a
Point estimates for the total outcomes prevented will not necessarily equal to the sum of the age group–specific point estimates. They represent the median total outcomes prevented from 5000 simulations of the model.